help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scharfmann, R.
Right arrow Articles by Czernichow, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scharfmann, R.
Right arrow Articles by Czernichow, P.

Endocrinology, Vol 134, 2321-2328, Copyright © 1994 by Endocrine Society


ARTICLES

Growth hormone and prolactin regulate the expression of nerve growth factor receptors in INS-1 cells

R Scharfmann, F Atouf, A Tazi and P Czernichow
INSERM CJF93-13, Hospital R. Debre, Paris, France.

We have previously demonstrated that beta-cells express both p75NGF-R and Trk-A, the low and high affinity nerve growth factor (NGF) receptors, respectively. In the current study, we provide evidences that in the beta-cell line INS-1, the expression of these receptors is tightly controlled by GH and PRL, two hormones implicated in beta-cell development and function. Within 24 h of treatment of INS-1 cells with human (h) GH, the numbers of low and high affinity NGF-binding sites, calculated after Scatchard analysis, increase 3- and 2.5-fold, respectively. The increase in the concentration of the high affinity NGF-binding sites is paralleled by an increase in Trk-A protein without any change at the mRNA steady state level, suggesting a translational/posttranslational effect. On the other hand, the increase in low affinity binding sites is paralleled by an increase in the p75NGF-R mRNA steady state level. The effect requires at least 8 h of treatment, and a dose of 50 ng/ml hGH is sufficient to induce an increase in the p75NGF-R mRNA steady state level. The effect of hGH can be mimicked in the same time- and dose-dependent manner by rat PRL and bovine GH, suggesting that the expression of NGF receptors can be transduced by both the somatogenic and lactogenic pathways. Finally, the increase in the p75NGF-R mRNA steady state level after PRL treatment is not due to mRNA stabilization, suggesting a transcriptional control, and requires concurrent protein synthesis. GH and PRL could thus be important regulators of the sensitivity of beta- cells to NGF.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
D. Le Roith, C. Bondy, S. Yakar, J.-L. Liu, and A. Butler
The Somatomedin Hypothesis: 2001
Endocr. Rev., February 1, 2001; 22(1): 53 - 74.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
M.A. Russo, M.L. Giustizieri, A. Favale, M.C. Fantini, L. Campagnolo, D. Konda, F. Germano, D. Farini, C. Manna, and G. Siracusa
Spatiotemporal Patterns of Expression of Neurotrophins and Neurotrophin Receptors in Mice Suggest Functional Roles in Testicular and Epididymal Morphogenesis
Biol Reprod, October 1, 1999; 61(4): 1123 - 1132.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Rosenbaum, R. Vidaltamayo, Ma. C. Sanchez-Soto, A. Zentella, and M. Hiriart
Pancreatic beta  cells synthesize and secrete nerve growth factor
PNAS, June 23, 1998; 95(13): 7784 - 7788.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society